Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Preferred Stock Liabilities (2022 - 2024)

Vsee Health filings provide 3 years of Preferred Stock Liabilities readings, the most recent being $1.3 million for Q1 2024.

  • On a quarterly basis, Preferred Stock Liabilities fell 82.67% to $1.3 million in Q1 2024 year-over-year; TTM through Mar 2024 was $1.3 million, a 82.67% decrease, with the full-year FY2023 number at $1.3 million, down 82.67% from a year prior.
  • Preferred Stock Liabilities hit $1.3 million in Q1 2024 for Vsee Health, roughly flat from $1.3 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $7.9 million in Q3 2023 to a low of $1.3 million in Q4 2023.
  • Median Preferred Stock Liabilities over the past 3 years was $7.4 million (2022), compared with a mean of $5.5 million.
  • The widest YoY moves for Preferred Stock Liabilities: up 82.67% in 2023, down 82.67% in 2023.
  • Vsee Health's Preferred Stock Liabilities stood at $7.4 million in 2022, then plummeted by 82.67% to $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024.
  • The last three reported values for Preferred Stock Liabilities were $1.3 million (Q1 2024), $1.3 million (Q4 2023), and $7.9 million (Q3 2023) per Business Quant data.